AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED
Clinical trials for AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED trials appear
Sign up with your email to follow new studies for AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lymphoma: targeted drug combo shows promise in early trial
Disease control OngoingThis phase 2 trial tests a combination of the targeted drug polatuzumab vedotin with standard chemotherapy (rituximab, ifosfamide, carboplatin, and etoposide) as an initial salvage therapy for patients with diffuse large B-cell lymphoma that has relapsed or not responded to treat…
Matched conditions: AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 26, 2026 12:54 UTC
-
New combo tackles tough lymphomas
Disease control OngoingThis early-phase trial tests the safety and best dose of combining two drugs—pembrolizumab (Keytruda) and vorinostat (Zolinza)—in people with certain lymphomas that have returned or not responded to treatment. Pembrolizumab helps the immune system attack cancer cells, while vorin…
Matched conditions: AGGRESSIVE B-CELL LYMPHOMA UNCLASSIFIED
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC